Drugs / rb-bFGF
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03574935 | Jul 2018 → Sep 2019 | ulcer disease | Shanghai Yueyang Integrated Medicine Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rb-bFGF | “3.rb-bFGF(lesions with no slough and look clear).” NCT03574935 ↗ |
| Modality | Protein / enzyme biologic | “bovine basic fibroblast growth factors (b-FGF) spray” NCT03574935 ↗ |
| Route | Topical | “Ethacridine Lactate Solution, 1% Sulfadiazine Silver Cream and rb-bFGF will be applied to cover the participants' lesions.” NCT03574935 ↗ |